Estimating risk of low radiation doses - A critical review of the BEIR VII report and its use of the linear no-threshold (LNT) hypothesis

Radiation Research

Volumn 182, Issue 5, 2014, Pages 463-474

  Calabrese, Edward J ^a   O'Connor, Michael K ^b  

^a UNIVERSITY OF MASSACHUSETTS   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATOMIC WARFARE; HUMAN; NEOPLASMS, RADIATION-INDUCED; OCCUPATIONAL EXPOSURE; RADIATION RESPONSE; RISK;

DOSE-RESPONSE RELATIONSHIP, RADIATION; HUMANS; NEOPLASMS, RADIATION-INDUCED; NUCLEAR WARFARE; OCCUPATIONAL EXPOSURE; RISK;

EID: 84914182948     PISSN: 00337587     EISSN: 19385404     Source Type: Journal    
DOI: 10.1667/RR13829.1     Document Type: Review

References (87)

1. Ionizing radiation exposure of the population of the United States. NCRP Report No. 160. Bethesda: National Council on Radiation Protection and Measurements; 2009.
2. Brenner DJ, Elliston CD. Estimated radiation risks potentially associated with full-body CT screening. Radiology 2004; 232:225-9.
3. Smith-Bindman R, Lipson J, Marcus R, Kim KP, Mahesh M, Gould R, et al. Radiation dose associated with common computed tomography examinations and the associated lifetime attributable risk of cancer. Arch Intern Med 2009; 169:2078-86.
4. Berrington de González A, Mahesh M, Kim KP, Bhargavan M, Lewis R, Mettler F, et al. Projected cancer risks from computed tomographic scans performed in the United States in 2007. Arch Intern Med 2009; 169:2071-7.
5. NCR, Health risks from exposures to low levels of ionizing radiation: BEIR VII Phase 2. National Research Council, Washington DC: National Academy Press; 2006.
6. Tubiana M, Aurengo A, Averbeck D, Bonnin A, LeGuen B, Masse R. Dose-effect relationships and estimation of the carcinogenic effect of low doses of ionizing radiation. Joint Report of the Academie des Sciences, Academie Nationale de Medecine: 2005.
7. Muller HJ. Artificial transmutation of the gene. Science 1927; 66:84-7.
8. Olson AR, Lewis GN. Natural reactivity and the origin of species. Nature 1928; 121:673-4.
9. Muller HJ, Mott-Smith LM. The frequency of translocations produced by x-rays in Drosophila. Genetics 1930; 15:283-331.
10. Giles N. Spontaneous chromosome aberrations in Tradescantia. Genetics 1940; 25:69-87.
11. Calabrese EJ. Origin of the linearity no threshold (LNT) doseresponse concept. Arch Toxicol 2013; 87:1621-33.
12. Calabrese EJ. How the U.S. National Academy of Sciences misled the world community on cancer risk assessment: new findings challenge historical foundations of the linear dose response. Arch Toxicol 2013; 87:2063-81.
13. Timofeeff-Ressovsky NW, Zimmer KG, Delbruck M. Uber die Natur der Genmutation und der Genstruktur. Nachrichten von der Gesellschaft der Wissenschaften zu Gottingen: Mathematische-Physikalische Klass, Fachgruppe VI. Biologie 1935; 1:189-245.
14. Calabrese EJ. The road to linearity: why linearity at low doses became the basis for carcinogen risk assessment. Arch Toxicol 2009; 83:203-25.
15. Calabrese EJ. Toxicology rewrites its history and rethinks its future: giving equal focus to both harmful and beneficial effects. Environ Toxicol Chem 2011; 30:2658-73.
16. NAS/National Research Council. The biological effects of atomic radiation. A report to the public. Washington DC; 1956.
17. Crow JF. Quarreling geneticists and a diplomat. Genetics 1995; 140:421-6.
18. Calabrese EJ. Key studies to support cancer risk assessment questioned. Environ Mol Mut 2011; 52:595-606.
19. Calabrese EJ. Muller's Nobel Prize lecture: when ideology prevailed over science. Toxicol Sci 2012; 126:1-4.
20. Uphoff DE, Stern C. The genetic effects of low intensity irradiation. Science 1949; 109:609-10.
21. Caspari E, Stern C. The influence of chronic irradiation with gamma rays at low dosages on the mutation rate in Drosophila melanogaster. Genetics 1948; 33:75-95.
22. Spencer WP, Stern C. Experiments to test the validity of the linear R-dose/mutation at low dosage. Genetics 1948; 33:43-74.
23. Calabrese EJ. Response to letter of Ralph J. Cicerone and Kevin Crowley regarding "How the U.S. National Academy of Sciences misled the world community on cancer risk assessment: New findings challenge historical foundations of the linear dose response." Arch Toxicol 2014; 88:173-7.
24. Kesavan PC. Linear, no threshold model in low-dose radiobiologyideology versus science. Curr Sci 2014; 107:46-53.
25. Oliver CP. The effect of varying the duration of X-ray treatment upon the frequency of mutation. Science 1930: 71:44-6.
26. Hanson FB, Heys F. Radium and lethal mutations in Drosophila; further evidence of the proportionality rule from the effects of equivalent doses differently applied. Am Nat 1932; 66:335-45.
27. Hanson FB, Heys F. An analysis of the effect of the different rays of radium in producing lethal mutations in Drosophila. Am Nat 1929; 63:201-13.
28. Weinstein A. The production of mutations and rearrangements of genes by X-rays. Science 1928; LXVII:376-7.
29. Stadler LJ. Some genetic effects of X-rays in plants. J Hered 1930; 21:3-19.
30. Serebrowsky AS, Dubinin NP. X-ray experiments with Drosophila. J Hered 1930; 21:259-65.
31. National Academies News Report. Low levels of ionizing radiation may cause harm. June 29, 2005. (http://www8.nationalacademies. org/onpinews/newsitem.aspx?RecordID=11340)
32. NRC, The effects on populations of exposure to low levels of ionizing radiation, BEIR III. National Research Council, Washington, DC: National Academy Press; 1980.
33. NRC, Health Effects of Exposure to Low Levels of ionizing radiation, BEIR V. National Research Council, Washington, DC: National Academy Press; 1990.
34. Jablon S, Hrubec Z, Boice JD. Cancer in populations living near nuclear facilities. A survey of mortality nationwide and incidence in two states. JAMA 1991; 265:1403-8
35. Tao Z, Cha Y, Sun Q. Cancer mortality in high background radiation area of Yangjiang, China, 1979-1995. Zhonghua Yi Xue Za Zhi. 1999; 79:487-92.
36. Cohen BL. Test of the linear-no threshold theory of radiation carcinogenesis for inhaled radon decay products. Health Phys 1995; 68:157-74.
37. Cohen BL. Lung cancer rate vs. mean radon level in U.S. counties of various characteristics. Health Phys 1997; 72:114-9.
38. NRC, Health effects of exposure to radon, BEIR VI. National Research Council, Washington, DC: National Academy Press; 1999.
39. Thompson RE, Nelson DF, Popkin JH, Popkin Z. Case-control study of lung cancer risk from residential radon exposure in Worcester County, Massachusetts. Health Phys 2008; 94:228-41.
40. Cardis E, Vrijheid M, Blettner M, Gilbert E, Hakama M, Hill C, et al. The 15-Country collaborative study of cancer risk among radiation workers in the nuclear industry: estimates of radiationrelated cancer risks. Radiat Res 2007; 167:396-416.
41. CNSC, Verifying Canadian nuclear energy worker radiation risk: a reanalysis of cancer mortality in Canadian nuclear energy workers (1957-1994): Summary report. Minister of Public Works and Government Services Canada. Catalogue number CC172-65/ 2011E-PDF. ISBN 978-1-100-17760-1. Canadian Nuclear Safety Commission; 2011.
42. Howe GR. Lung cancer mortality between 1950 and 1987 after exposure to fractionated moderate-dose-rate ionizing radiation in the Canadian fluoroscopy cohort study and a comparison with lung cancer mortality in the atomic bomb survivors study. Radiat Res 1995; 142:295-304.
43. Howe GR, McLaughlin J. Breast cancer mortality between 1950 and 1987 after exposure to fractionated moderate-dose-rate ionizing radiation in the Canadian fluoroscopy cohort study and a comparison with breast cancer mortality in the atomic bomb survivors study. Radiat Res 1996; 145:694-707.
44. Lundell M, Mattsson A, Hakulinen T, Holm LE. Breast cancer after radiotherapy for skin hemangioma in infancy. Radiat Res 1996; 145:225-30.
45. Lundell M, Holm LE. Mortality from leukemia after irradiation in infancy for skin hemangioma. Radiat Res 1996; 145:595-601.
46. Lundell M, Mattsson A, Karlsson P, Holmberg E, Gustafsson A, Holm LE. Breast cancer risk after radiotherapy in infancy: a pooled analysis of two Swedish cohorts of 17,202 infants. Radiat Res 1999; 151:626-32.
47. Preston DL, Ron E, Tokuoka S, Funamotm S, Nishi N, Soda M, et al. Solid cancer incidence in atomic bomb survivors: 1958-1998. Radiat Res 2007; 168:1-64.
48. Ozasa K, Shimizu Y, Suyama A, Kasagi F, Soda M, Grant EJ, et al. Studies of the mortality of atomic bomb survivors, Report 14, 1950-2003: an overview of cancer and noncancer diseases. Radiat Res 2012; 177:229-43.
49. Doss M, Egleston BL, Litwin S. Comments on "Studies of the mortality of atomic bomb survivors, report 14, 1950-2003: an overview of cancer and noncancer diseases". Radiat Res 2012; 178:244-5.
50. Radiat Res 177, 229-243, 2012.
51. Doss M. Linear no-threshold model vs. radiation hormesis. Dose Response 2013; 11:480-97.
52. UNSCEAR, Sources and effects of ionizing radiation. New York: United Nations; 1993.
53. Dauer LT, Brooks AL, Hoel DG, Morgan WF, Stram D, Tran P. Review and evaluation of updated research on the health effects associated with low-dose ionizing radiation. Radiat Prot Dosimet 2010; 140:103-36.
54. Brooks AL, Dauer LT. Advances in radiation biology: effect on nuclear medicine. Semin Nucl Med 2014; 44:179-86.
55. Hendee WR, O'Connor MK. Radiation risks of medical imaging: separating fact from fantasy. Radiology 2012; 264:312-21.
56. UNSCEAR, Chapter II, Section 1(f) Attributing health effects to radiation exposure and inferring risks. Report of the United Nations Scientific Committee on the effects of atomic radiation - Fifty-ninth session, 21-25 May 2012, Supplement No. 46. New York: United Nations; 2012.
57. Zimmer KG. Ergebnisse und Grenzen der treffertheoretischen Deutung von strahlenbiologischen Dosis-Effekt-Kurven. Biol Zentral 1941; 63:78.
58. Haas FI, Clark JB, Wyss O, Stone WS. Mutations and mutagenic agents in bacteria. Am Nat 1950; 84:261-74.
59. Kimball RF. Genetic effects of radiation. Ann Rev Nucl Sci 1952; 1:479-94.
60. Collinson E, Dainton FS, Smith DR, Tazuke S. Evidence for unit negative charge on hydrogen atom formed by action of ionising radiation on aqueous systems. Proc Chem Soc 1962; 140-4.
61. Czapski G, Schwarz HA. The nature of the reducing radical in water radiolysis. J Phys Chem 1962; 66:471-9.
62. Weiss J. Radiochemistry of aqueous solutions. Nature 1944; 153:748-50.
63. Hanawalt PC. Evolution of concepts in DNA repair. Environ Mol Mut 1994; 23(suppl 24):78-85.
64. Samson L, Cairns J. New pathway for DNA-repair in Escherichia coli. Nature 1977; 267:281-3.
65. Olivieri G, Bodycote J, Wolff S. Adaptive response of human lymphocytes to low concentrations of radioactive thymidine. Science 1984; 223:594-7.
66. Calabrese EJ, Baldwin LA. Toxicology rethinks its central belief - hormesis demands a reappraisal of the way risks are assessed. Nature 2003; 421:691-2.
67. Calabrese EJ. Hormesis: why it is important to toxicology and toxicologists. Environ Toxicol Chem 2008; 27:1451-74.
68. Sanders CL. Radiation hormesis and the linear-no-threshold assumption. Heidelberg, Germany: Springer-Verlag; 2010.
69. Scott BR. Stochastic thresholds: a novel explanation of nonlinear dose-response relationships for stochastic radiobiological effects. Dose Response 2006; 3:547-67.
70. Scott BR. Low-dose radiation-induced protective process and implications for risk assessment, cancer prevention, and cancer therapy. Dose Response 2007; 5:131-49.
71. Scott BR. It's time for a new low-dose-radiation risk assessment paradigm one that acknowledges hormesis. Dose Response 2008; 6:333-51.
72. Bruce RD, Carlton WW, Ferber KH, Hughes DH, Quast JF, Salsburg DS, et al. Reexamination of the ED01 study why the society of toxicology became involved. Fund Appl Toxicol 1981; 1:26-128.
73. Fukushima S, Kinoshita A, Puatanachokchai R, Kushida M, Wanibuchi H, Morimura K. Hormesis and dose-response-mediated mechanisms in carcinogenesis: evidence for a threshold in carcinogenicity of non-genotoxic carcinogens. Carcinogenesis 2005; 26:1835-45.
74. Sukata T, Uwagawa S, Ozaki K, Ogawa M, Nishikawa T, Iwai S, et al. Detailed low-dose study of 1,1-bis(p-chlorophenyl)-2,2,2- trichloroethane carcinogenesis suggests the possibility of a hormetic effect. Int J Cancer 2002; 99:112-8.
75. Ina Y, Sakai K. Further study of prolongation of life span associated with immunological modification by chronic low-doserate irradiation in MRL-1pr/1pr mice: effects of whole-life irradiation. Radiat Res 2005; 163:418-23.
76. Ina Y, Tanooka H, Yamada T, Sakai K. Suppression of thymic lymphoma induction by lifelong low-dose-rate irradiation accompanied by immune activation in C57BL/6 mice. Radiat Res 2005; 63:153-8.
77. Ludovico P, Burhans WC. Reactive oxygen species, ageing and the hormesis police. FEMS yeast research 2013; 14:33-9.
78. Williams GM, Iatropoulos MJ, Jeffrey AM. Thresholds for DNAreactive (genotoxic) organic carcinogens. Toxicol Pathol 2005; 18:69-77.
79. Driver HE, White IH, Butler WH. Dose-response relationships in chemical carcinogenesis: renal mesenchymal tumours induced in the rat by single dose dimethylnitrosamine. Br J Exp Path 1987; 68:133-43.
80. Albert RE. Carcinogen risk assessment in the U.S. environmental protection agency. Crit Rev Toxicol 1994; 24:75-85.
81. Calabrese EJ. Principles of animal extrapolation. New York: John Wiley and Sons, Inc; 1983.
82. Taubes G, Mann CC. Epidemiology faces its limits. Science 1995; 269:164-9.
83. Ioannidis JPA. Why most published research findings are false. PLoS Med 2005; 2:e124.
84. Carruth RS, Goldstein BD. Relative risk greater than two in proof of causation in toxic tort litigation. Jurimetrics 2001; 41:195-209.
85. Calabrese EJ, Blain R. The occurrence of hormetic dose responses in the toxicological literature, the hormesis database: an overview. Toxicol Appl Pharm 2005; 202:289-301.
86. Calabrese EJ, Blain R. The hormesis database: the occurrence of hormetic dose responses in the toxicological literature. Reg Toxicol Pharm 2011; 61:73-81.
87. Calabrese EJ. The dose-response: A fundamental concept in toxicology. In: AW Hayes, Editor. Principles and methods of toxicology, 6th ed. Boca Raton FL: CRC Press; 2014.